Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04811001
Title Best EGFR-TKI Sequence in NSCLC Harboring EGFR Mutations (CAPLAND)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Fondazione Ricerca Traslazionale
Indications

lung non-small cell carcinoma

Therapies

Dacomitinib

Osimertinib

Age Groups: adult | senior
Covered Countries ITA

Additional content available in CKB BOOST